Komodo Health

The FDA’s Clozapine REMS program was designed to protect patients, but are the benefits outweighing the costs? Our recent study provides essential real-world data to answer that question. https://lnkd.in/ehSpvXye #ISPE2024 #FDA #RWE

Commercial teams: Are you leveraging predictive analytics to ensure timely engagement of HCPs? In this 3-minute video clip, you’ll learn how an algorithm based on lab results enabled a customer to identify patients on the pathway to a third-line therapy. Learn more here: https://lnkd.in/gDiSxW5k

Unlock the power of advanced analytics with MapAI™️. From creating patient cohorts to exploring the distribution of treating-HCPs, MapAI makes data insights accessible and actionable. Discover the future of healthcare analytics powered by real-world evidence. See MapAI in action: https://lnkd.in/e-rJQ9R5 #HealthcareData #AIAssistant #MapAI #KomodoHealth #pharmaceuticals #PharmaceuticalIndustry #fda

In late 2023, the first dedicated at-home drug for #PostpartumDepression (PPD) became available. In our new analysis, we asked: exactly how common is #PPD and who is getting this pricey but important new treatment? See what we found. https://bit.ly/3AZiegE

Life Sciences teams often choose to work exclusively with either open or closed claims data, depending on the use case. But today — as drug therapies cross both Rx and Mx benefits and HEOR studies are enriched with EHR data — teams across the product life cycle are reevaluating their approaches to insight generation. You should, too. Read our article: https://lnkd.in/emzg7nk9 #pharmaceuticalindustry #pharmaceuticals #lifesciences #fda

WATCH: In a recent webinar, we unveiled exciting updates to Komodo's MapLab solution—including the debut of MapAI and MapExplorer—tools that elevate insights and streamline decision-making with intuitive, no-code workflows. Catch the full webinar recording to explore what these new features mean for you and how they can transform your workflows. https://lnkd.in/e_yZdB6B #HealthcareInnovation #DataScience #MapLab #Pharma #PharmaceuticalsIndustry

Catch up on the latest Komodo news: We're proud to partner with Fight Colorectal Cancer to drive bold goals for improving outcomes in colorectal cancer. Learn how real-world insights are paving the way for timely screening, diagnosis, and treatment: https://lnkd.in/e5nVxCM4 Statistics on postpartum depression (PPD) in the US are lacking. With the launch of a groundbreaking dedicated PPD drug last year, we looked at which women were most likely to seek treatment, and what treatments - if any - they’re getting. https://lnkd.in/e8CWEVkA HPV vaccination has revolutionized cervical cancer risk for a young cohort of patients. BUT high-risk HPV is on the rise and fewer patients are getting follow-up care. We dove into the data to see how recent trends may put women at risk. https://lnkd.in/eGMk_MDj The FDA’s Clozapine REMS program was designed to protect patients, but are the benefits outweighing the costs? Our recent study provides essential real-world data to answer that question. https://lnkd.in/ehSpvXye An industry survey conducted by Frost & Sullivan revealed it takes an average of 4 data vendors and 7 months just to integrate the data — before insight generation can even begin. There is a better way: https://lnkd.in/eQ_DxF5B #PharmaceuticalIndustry #pharmaceuticals #LifeSciences #CervicalCancer #HPV #PostpartumDepression #womenshealth #colorectalcancer #ISPE2024 #FDA #RWE #RWD

Understanding HCRU and cost by care setting is one of HEOR teams’ greatest challenges. The lack of standardization across datasets, redacted payer info in claims, and missing data variables make it nearly impossible. That’s why our research data schema and cost imputation model (built on 4.4 billion healthcare claims) are so valuable. Learn more: https://lnkd.in/dGTUXFs3 #fda #pharmaceuticalindustry #pharmaceuticals #lifesciences 

What if you could turn scattered data into game-changing insights? In our on-demand webinar, discover how MapEnhance integrates diverse datasets—genomics, lab results, and social determinants of health—to drive smarter, faster decisions. See how commercial teams are using MapEnhance to pinpoint key sub-populations, refine treatment strategies, and accelerate outcomes. Ready to turn fragmented data into your competitive advantage? Watch now to see how MapEnhance streamlines your approach and drives faster results: https://lnkd.in/eH_3sc-g #HealthcareData #LifeSciences #PatientInsights #PatientJourney

New analytic tools and real-world evidence can transform how we assess federal safety programs. See how Komodo’s latest study can help guide FDA decision-making on Clozapine REMS. https://lnkd.in/ehSpvXye #RWE #FDA #ISPE2024